Jilong Wang

2.3k total citations
46 papers, 1.5k citations indexed

About

Jilong Wang is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Jilong Wang has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 15 papers in Molecular Biology and 14 papers in Biomedical Engineering. Recurrent topics in Jilong Wang's work include Nanoplatforms for cancer theranostics (13 papers), Immunotherapy and Immune Responses (12 papers) and Nanoparticle-Based Drug Delivery (11 papers). Jilong Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Immunotherapy and Immune Responses (12 papers) and Nanoparticle-Based Drug Delivery (11 papers). Jilong Wang collaborates with scholars based in China, United States and France. Jilong Wang's co-authors include Jun Wang, Zhiting Cao, Xiao‐Jiao Du, Hongjun Li, Yucai Wang, Xiaodong Ye, Ying‐Li Luo, Jin‐Zhi Du, Xianzhu Yang and Shoaib Iqbal and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and Biomaterials.

In The Last Decade

Jilong Wang

45 papers receiving 1.5k citations

Peers

Jilong Wang
Sanyogitta Puri United Kingdom
Anna Scomparin Israel
Satya Siva Kishan Yalamarty United States
Zhirong Zhong China
Sang Mun Bae South Korea
Yingjuan Lu United States
Edgar Pérez‐Herrero Spain
Jianqin Wan China
Nina Filipczak United States
Zhiting Cao China
Sanyogitta Puri United Kingdom
Jilong Wang
Citations per year, relative to Jilong Wang Jilong Wang (= 1×) peers Sanyogitta Puri

Countries citing papers authored by Jilong Wang

Since Specialization
Citations

This map shows the geographic impact of Jilong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jilong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jilong Wang more than expected).

Fields of papers citing papers by Jilong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jilong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jilong Wang. The network helps show where Jilong Wang may publish in the future.

Co-authorship network of co-authors of Jilong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jilong Wang. A scholar is included among the top collaborators of Jilong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jilong Wang. Jilong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jilong, Yiran Wang, Kerui Wu, et al.. (2024). Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy. Biomaterials. 311. 122710–122710. 8 indexed citations
2.
Jiang, Hongyi, Tian Xia, Liting Jiang, et al.. (2024). Chemotactic recruitment of genetically engineered cell membrane-camouflaged metal−organic framework nanoparticles for ischemic osteonecrosis treatment. Acta Biomaterialia. 185. 410–428. 6 indexed citations
3.
Li, Wanyu, Yan Zhuo, Zhihao Chen, et al.. (2024). Hydrogel based on M1 macrophage lysate and alginate loading with oxaliplatin for effective immunomodulation to inhibit melanoma progression, recurrence and metastasis. International Journal of Biological Macromolecules. 280(Pt 2). 135542–135542. 3 indexed citations
4.
Li, Wanyu, Yan Zhuo, Dan Wang, et al.. (2024). A cross-linked macropore hydrogel based on M1 macrophage lysate and alginate regulates tumor-associated macrophages for the treatment of melanoma. International Journal of Biological Macromolecules. 269(Pt 2). 132089–132089. 6 indexed citations
5.
Xia, Tian, Yuting Zhu, Kaiqiang Li, et al.. (2024). Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis. Journal of Nanobiotechnology. 22(1). 103–103. 28 indexed citations
6.
Luo, Ying‐Li, Xianyu Luo, Dongdong Li, et al.. (2024). Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H2S-amplified nanoformulation to enhance cancer immunotherapy. Acta Pharmaceutica Sinica B. 15(3). 1242–1254. 4 indexed citations
7.
Jiang, Hongyi, et al.. (2024). Immunosuppressive microvesicles-mimetic derived from tolerant dendritic cells to target T-lymphocytes for inflammation diseases therapy. Journal of Nanobiotechnology. 22(1). 201–201. 10 indexed citations
8.
Zhang, Pingfan, Jia Jia, Yujia Wang, et al.. (2023). Metal-free 2D/2D VdW heterojunction fabricated by amorphous covalent triazine frameworks with nitrogen-defect on polymeric carbon nitride towards enhanced photocatalytic performance. Separation and Purification Technology. 330. 125224–125224. 12 indexed citations
9.
Lou, Chao, Hongyi Jiang, Tian Xia, et al.. (2023). MiR-146b-5p enriched bioinspired exosomes derived from fucoidan-directed induction mesenchymal stem cells protect chondrocytes in osteoarthritis by targeting TRAF6. Journal of Nanobiotechnology. 21(1). 486–486. 30 indexed citations
10.
Deng, Junjie, Jilong Wang, Jiaqi Shi, et al.. (2021). Tailoring the physicochemical properties of nanomaterials for immunomodulation. Advanced Drug Delivery Reviews. 180. 114039–114039. 38 indexed citations
11.
Wang, Yang, Xiao‐Jiao Du, Jilong Wang, et al.. (2020). Co-inhibition of the TGF-β pathway and the PD-L1 checkpoint by pH-responsive clustered nanoparticles for pancreatic cancer microenvironment regulation and anti-tumor immunotherapy. Biomaterials Science. 8(18). 5121–5132. 77 indexed citations
12.
Cao, Zhiting, Wei Jiang, Jilong Wang, et al.. (2020). Protein Binding Affinity of Polymeric Nanoparticles as a Direct Indicator of Their Pharmacokinetics. ACS Nano. 14(3). 3563–3575. 60 indexed citations
13.
Li, Qinghua, et al.. (2020). Hypoxia-responsive nanogel as IL-12 carrier for anti-cancer therapy. Nanotechnology. 32(9). 95107–95107. 20 indexed citations
14.
Zhu, Yanhua, Jilong Wang, Houbing Zhang, et al.. (2019). Incorporation of a rhodamine B conjugated polymer for nanoparticle trafficking both in vitro and in vivo. Biomaterials Science. 7(5). 1933–1939. 11 indexed citations
15.
Wang, Jilong, Xiao‐Jiao Du, Jinxian Yang, et al.. (2018). The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles. Biomaterials. 182. 104–113. 89 indexed citations
16.
Wang, Jilong, et al.. (2018). Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy. Biomaterials Science. 6(7). 1916–1922. 19 indexed citations
17.
Zhang, Yuling, et al.. (2017). Biodegradation of Poly(Aspartic Acid-Itaconic Acid) Copolymers by Miscellaneous Microbes from Natural Water. Journal of environmental polymer degradation. 26(1). 116–121. 1 indexed citations
18.
Cao, Zhiting, Zhiyao Chen, Chunyang Sun, et al.. (2016). Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles. Biomaterials. 94. 9–19. 52 indexed citations
19.
Du, Xiao‐Jiao, Jilong Wang, Weiwei Liu, et al.. (2015). Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo. Biomaterials. 69. 1–11. 87 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanyogitta Puri Breakdown of academic impact, for papers by Anna Scomparin Breakdown of academic impact, for papers by Satya Siva Kishan Yalamarty Breakdown of academic impact, for papers by Zhirong Zhong Breakdown of academic impact, for papers by Sang Mun Bae Breakdown of academic impact, for papers by Yingjuan Lu Breakdown of academic impact, for papers by Edgar Pérez‐Herrero Breakdown of academic impact, for papers by Jianqin Wan Breakdown of academic impact, for papers by Nina Filipczak Breakdown of academic impact, for papers by Zhiting Cao
Rankless by CCL
2026